RxDoctor Payments Data

Kristopher Hanson, MD

Internal Medicine · Dublin, OHNPI 1174675268

Payments from drug & device makers

$670in general payments, 2019–2025

Across 37 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$159
  • Boston Scientific$67
  • Astellas Pharma US Inc$56
  • AstraZeneca$51
  • Corcept Therapeutics$49
  • Xeris Pharmaceuticals, Inc.$39
  • plus $250 from 10 others

What the payments were for

  • Food & beverage$670100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$670 in reported general payments places this provider in the 70th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$141,211
Medicare patients
362
Services billed
6,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban165$162,046
OzempicSemaglutide67$66,812
JardianceEmpagliflozin27$46,218
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$35,597
JanuviaSitagliptin Phosphate28$31,100
XareltoRivaroxaban18$19,965
JanumetSitagliptin Phos/Metformin Hcl13$19,922
FarxigaDapagliflozin Propanediol16$12,698
Spiriva RespimatTiotropium Bromide13$8,884
Synjardy XrEmpagliflozin/Metformin Hcl23$6,514
ShingrixVaricella-Zoster Ge/As01b/Pf20$4,403
Atorvastatin Calcium477$3,432
SynthroidLevothyroxine Sodium75$2,859
Losartan Potassium246$2,462
Tamsulosin Hcl125$2,370

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$25$163,475179 claims
Novo NordiskOzempic$159$66,81267 claims
GSKTrelegy Ellipta, Shingrix$29$40,00064 claims
AstraZenecaFarxiga$51$12,69816 claims
AbbVieSynthroid$38$2,85975 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Dublin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →